ASARI TETSUYA,KIYONO YUJI,AOYAMA AKITOSHI,YOSHIDA TAKUMITSU
申请号：
IN201717035357
公开号：
IN201717035357A
申请日:
2017.10.05
申请国别(地区):
IN
年份:
2017
代理人:
摘要：
The present invention pertains to a pharmaceutical composition that contains ozagrel or a pharmacologically acceptable salt thereof as an active ingredient and that is for treating dry eye associated with Sjogren s syndrome. The pharmaceutical composition of the present invention has a strong tendency to persist even after administration of an eye drop of a general therapeutic agent (e.g. artificial tears etc.) for dry eye and exhibits particularly excellent therapeutic effect for treating disorders of the conjunctiva epithelium and the cornea related to dry eye associated with Sjogren s syndrome. Thus the pharmaceutical composition of the present invention is useful as a pharmaceutical composition for treating dry eye associated with Sjogren s syndrome.
